Legal Affairs

Texas Broadens Medical Cannabis Access Amid THC Policy Shift

LOS ANGELES- Texas has enacted House Bill 46, expanding its Compassionate Use Program for medical cannabis. The law, effective September 1, adds qualifying conditions such as chronic pain, Crohn’s disease and traumatic brain injury. It raises the per‑dose ...

Cronos Expands Medical Cannabis Presence in Switzerland

LOS ANGELES- Cronos Group Inc. has entered the Swiss medical cannabis market through a partnership with Dascoli Pharma AG, a Zurich-based pharmaceutical distributor. The deal enables Dascoli to supply five varieties of the company's PEACE NATURALS branded ...

Planet 13 Reports Q2 2024 Revenue Growth

LOS ANGELES- Planet 13 Holdings Inc. a vertically integrated multistate cannabis operator, announced its financial results for the second quarter of 2024, highlighting robust revenue growth driven by strategic acquisitions and expanding operations. For the ...

Cresco Labs Reports Q2 2024 Financial Results

LOS ANGELES- Cresco Labs Inc. has released its financial results for the second quarter of 2024, showcasing significant improvements in profitability and maintaining strong market positions across several states. Key highlights from the report include: ...

Trulieve Reports Q2 2024 Financial Results

LOS ANGELES- Trulieve announced its financial results for the second quarter ending June 30, 2024. The results, reported in U.S. dollars and following U.S. Generally Accepted Accounting Principles (GAAP), reflect continued growth and operational expansion. ...

Ohio to Launch Recreational Cannabis Sales 

LOS ANGELES- Ohio will commence recreational cannabis sales early next week, possibly as soon as Tuesday, August 6, following the issuance of the first necessary licenses on Monday. Jamie Crawford, Public Information Officer for Ohio’s ...

Tilray Expands Medical Cannabis Portfolio in Portugal

LOS ANGELES- Tilray Brands, Inc.  has announced a new achievement in its European medical cannabis operations. The company received approval for its new product, Tilray Solução Oral THC10, in Portugal. This follows earlier approvals for ...

Curaleaf Earnings Estimates Lowered

LOS ANGELES- Analysts at Atb Cap Markets have revised their Q2 2024 earnings estimates for Curaleaf Holdings, Inc. now forecasting a loss of $0.04 per share, down from a previous estimate of $0.03 per share. ...

Subscribe To Our Newsletter